+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Nuclear Medicine & Radiopharmaceuticals Market - Global Forecast 2026-2032- Product Image
Nuclear Medicine & Radiopharmaceuticals Market - Global Forecast 2026-2032- Product Image
New

Nuclear Medicine & Radiopharmaceuticals Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 194 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6127400
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Nuclear Medicine & Radiopharmaceuticals Market is swiftly advancing as precision healthcare demands evolve. Senior leaders must navigate complex operations, resilient supply chains, and emergent therapies, where strategic alignment is essential for competitive growth and sustained impact.

Market Snapshot: Nuclear Medicine & Radiopharmaceuticals Market

The Nuclear Medicine & Radiopharmaceuticals Market expanded from USD 9.52 billion in 2025 to USD 10.07 billion in 2026. It is projected to grow at a CAGR of 6.83%, reaching USD 15.12 billion by 2032. Market growth builds on the convergence of diagnostic and therapeutic platforms, with particular emphasis on scalable supply chains and robust clinical adoption.

Scope & Segmentation

This comprehensive report offers senior decision-makers clarity on stakeholder priorities and the key market segments shaping the nuclear medicine and radiopharmaceuticals space.

  • Product Types: Covers diagnostic and therapeutic radiopharmaceuticals, along with theranostic agents and companion imaging solutions that provide critical support for patient selection and individualized care.
  • Radioisotope Use: Addresses both established isotopes (technetium-99m, fluorine-18) and next-generation emitters (lutetium-177, actinium-225), detailing implications for operations and reliable sourcing across an expanding treatment landscape.
  • Applications: Explores a range of clinical uses, from oncology and cardiology to neurology, inflammation, and infection imaging, as well as rapidly emerging indications that drive procedural innovation.
  • End Users: Looks at hospitals, specialty clinics, imaging centers, academic healthcare institutions, and comprehensive health systems, examining protocol adoption and infrastructure maturity relevant to operational leaders.
  • Distribution Channels: Evaluates hospital radiopharmacy models and centralized radiopharmacy solutions, with a focus on workflow integration and scalable deployment for expanding care access.
  • Regions Covered: Reviews opportunities and challenges across the Americas, Europe, Middle East & Africa, and Asia-Pacific, considering site readiness, reimbursement systems, and efficient isotope logistics.
  • Key Technologies: Assesses cyclotron and reactor-based isotope production, digital workflow integration, advanced scheduling, compliance platforms, and AI-powered imaging analytics supporting greater accuracy and efficiency.

Key Takeaways

  • Adoption of targeted radionuclide therapies is accelerating, shifting market position from niche applications toward broader integration in mainstream care delivery.
  • Resilient operations hinge on localized production, redundancy in isotope supply, and mitigation of supply chain disruptions to maintain workflow continuity.
  • Standardized clinical protocols and digital traceability platforms are raising consistency in patient selection, dose management, and longitudinal monitoring for improved treatment outcomes.
  • Investment by major pharmaceutical organizations is intensifying competition, emphasizing executional capability, reliability, and regulatory alignment throughout the value chain.
  • Growth rates and scalability vary by region, dependent on reimbursement structures, regulatory requirements, and stability of local supply channels for specialty isotopes.
  • Institutional capacity is influenced by workforce expertise, highlighting the continued need for radiochemistry training and site enablement to ensure high-quality clinical delivery.

Tariff Impact

Anticipated U.S. tariff changes in 2025 are expected to introduce greater complexity into the Nuclear Medicine & Radiopharmaceuticals Market through impacts on procurement and supply chain management.

  • Procurement cycles may lengthen and costs may increase for inputs such as enriched target materials, shielding components, precision equipment, and sterile consumables, pressing providers to review sourcing models.
  • Additional regulatory compliance tasks arise when new suppliers or equipment substitutions require validation, documentation, and process adjustments.
  • These changes may prompt accelerated localization, shifting competition as more qualified suppliers enter the field and increasing the need to strengthen supply chain resilience.
  • Indirect operational pressures are likely, including risks of downtime, added engineering requirements, and potential delays in expanding capacity to meet growing demand.

Methodology & Data Sources

This analysis combines secondary sources, such as regulatory documents, industry filings, clinical research, and scientific literature, with primary research through structured interviews with manufacturers, isotope producers, clinicians, and procurement leaders. Triangulation ensures precise, actionable perspectives for B2B strategic planning.

Why This Report Matters

  • Enables executive teams to align product design, operational practices, and supply strategies with evolving clinical demands and regulatory expectations in the nuclear medicine and radiopharmaceuticals sector.
  • Emphasizes how technological progress, resilient supply chains, and regional site readiness converge to define strategy and market advantage.
  • Provides practical intelligence for navigating policy changes, supply friction, and the rapid development of nuclear medicine applications, supporting data-driven decision-making.

Conclusion

Sustained performance in the Nuclear Medicine & Radiopharmaceuticals Market rests on operational leadership, flexible supply strategies, and proactive site enablement. Organizations that prioritize these strengths will advance scalable implementation of precision therapeutics.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Nuclear Medicine & Radiopharmaceuticals Market, by Product Type
8.1. Diagnostic Radiopharmaceuticals
8.1.1. PET Radiopharmaceuticals
8.1.1.1. F-18 Radiopharmaceuticals
8.1.1.2. Ga-68 Radiopharmaceuticals
8.1.2. SPECT Radiopharmaceuticals
8.1.2.1. Non Tc-99m Radiopharmaceuticals
8.1.2.2. Tc-99m Radiopharmaceuticals
8.2. Therapeutic Radiopharmaceuticals
8.2.1. Alpha Emitting Radiopharmaceuticals
8.2.2. Beta Emitting Radiopharmaceuticals
8.2.2.1. I-131 Based Therapies
8.2.2.2. Lu-177 Based Therapies
8.2.2.3. Y-90 Based Therapies
9. Nuclear Medicine & Radiopharmaceuticals Market, by Isotope Type
9.1. Cyclotron Produced Isotopes
9.1.1. C-11
9.1.2. F-18
9.2. Generator Based Isotopes
9.2.1. Ge-68 Ga-68 Generators
9.2.2. Mo-99 Tc-99m Generators
10. Nuclear Medicine & Radiopharmaceuticals Market, by Application
10.1. Bone Imaging
10.2. Cardiology
10.3. Inflammation Imaging
10.4. Neurology
10.5. Oncology
11. Nuclear Medicine & Radiopharmaceuticals Market, by End User
11.1. Ambulatory Care Facilities
11.2. Diagnostic Imaging Centers
11.3. Hospital Radiology Departments
11.4. Research Organizations
12. Nuclear Medicine & Radiopharmaceuticals Market, by Distribution Channel
12.1. Offline
12.2. Online
13. Nuclear Medicine & Radiopharmaceuticals Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Nuclear Medicine & Radiopharmaceuticals Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Nuclear Medicine & Radiopharmaceuticals Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Nuclear Medicine & Radiopharmaceuticals Market
17. China Nuclear Medicine & Radiopharmaceuticals Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Advanced Accelerator Applications S.A.
18.6. AstraZeneca PLC
18.7. Bayer AG
18.8. Bracco Imaging S.p.A.
18.9. Bristol-Myers Squibb Company
18.10. BWX Technologies, Inc.
18.11. Cardinal Health, Inc.
18.12. Clarity Pharmaceuticals Ltd.
18.13. Curium Pharma
18.14. Eckert & Ziegler SE
18.15. Eli Lilly and Company
18.16. GE HealthCare Technologies Inc.
18.17. Ion Beam Applications S.A.
18.18. ITM Isotope Technologies Munich SE
18.19. Jubilant Pharmova Limited
18.20. Lantheus Holdings, Inc.
18.21. NorthStar Medical Radioisotopes, LLC
18.22. Novartis AG
18.23. Siemens Healthineers AG
18.24. Telix Pharmaceuticals Limited
List of Figures
FIGURE 1. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY F-18 RADIOPHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY F-18 RADIOPHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY F-18 RADIOPHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GA-68 RADIOPHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GA-68 RADIOPHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GA-68 RADIOPHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY NON TC-99M RADIOPHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY NON TC-99M RADIOPHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY NON TC-99M RADIOPHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY TC-99M RADIOPHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY TC-99M RADIOPHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY TC-99M RADIOPHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTING RADIOPHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTING RADIOPHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTING RADIOPHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTING RADIOPHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTING RADIOPHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTING RADIOPHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTING RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY I-131 BASED THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY I-131 BASED THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY I-131 BASED THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY LU-177 BASED THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY LU-177 BASED THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY LU-177 BASED THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY Y-90 BASED THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY Y-90 BASED THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY Y-90 BASED THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE TYPE, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED ISOTOPES, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED ISOTOPES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED ISOTOPES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED ISOTOPES, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY C-11, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY C-11, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY C-11, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY F-18, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY F-18, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY F-18, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED ISOTOPES, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED ISOTOPES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED ISOTOPES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED ISOTOPES, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GE-68 GA-68 GENERATORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GE-68 GA-68 GENERATORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GE-68 GA-68 GENERATORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY MO-99 TC-99M GENERATORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY MO-99 TC-99M GENERATORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY MO-99 TC-99M GENERATORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BONE IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BONE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BONE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY INFLAMMATION IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY INFLAMMATION IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY INFLAMMATION IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY AMBULATORY CARE FACILITIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY AMBULATORY CARE FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY AMBULATORY CARE FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITAL RADIOLOGY DEPARTMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITAL RADIOLOGY DEPARTMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITAL RADIOLOGY DEPARTMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTING RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE TYPE, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED ISOTOPES, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED ISOTOPES, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTING RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE TYPE, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED ISOTOPES, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED ISOTOPES, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTING RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 138. LATIN AMERICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE TYPE, 2018-2032 (USD MILLION)
TABLE 139. LATIN AMERICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED ISOTOPES, 2018-2032 (USD MILLION)
TABLE 140. LATIN AMERICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED ISOTOPES, 2018-2032 (USD MILLION)
TABLE 141. LATIN AMERICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 142. LATIN AMERICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTING RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE TYPE, 2018-2032 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED ISOTOPES, 2018-2032 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED ISOTOPES, 2018-2032 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 157. EUROPE NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 158. EUROPE NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 159. EUROPE NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 160. EUROPE NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 161. EUROPE NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 162. EUROPE NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 163. EUROPE NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTING RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 164. EUROPE NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE TYPE, 2018-2032 (USD MILLION)
TABLE 165. EUROPE NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED ISOTOPES, 2018-2032 (USD MILLION)
TABLE 166. EUROPE NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED ISOTOPES, 2018-2032 (USD MILLION)
TABLE 167. EUROPE NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 168. EUROPE NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 169. EUROPE NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 170. MIDDLE EAST NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. MIDDLE EAST NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 172. MIDDLE EAST NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 173. MIDDLE EAST NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 174. MIDDLE EAST NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 175. MIDDLE EAST NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 176. MIDDLE EAST NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTING RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 177. MIDDLE EAST NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE TYPE, 2018-2032 (USD MILLION)
TABLE 178. MIDDLE EAST NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED ISOTOPES, 2018-2032 (USD MILLION)
TABLE 179. MIDDLE EAST NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED ISOTOPES, 2018-2032 (USD MILLION)
TABLE 180. MIDDLE EAST NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 181. MIDDLE EAST NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 182. MIDDLE EAST NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 183. AFRICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. AFRICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 185. AFRICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 186. AFRICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 187. AFRICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 188. AFRICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 189. AFRICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTING RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 190. AFRICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE TYPE, 2018-2032 (USD MILLION)
TABLE 191. AFRICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED ISOTOPES, 2018-2032 (USD MILLION)
TABLE 192. AFRICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED ISOTOPES, 2018-2032 (USD MILLION)
TABLE 193. AFRICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 194. AFRICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 195. AFRICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 197. ASIA-PACIFIC NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 198. ASIA-PACIFIC NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 199. ASIA-PACIFIC NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 200. ASIA-PACIFIC NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 201. ASIA-PACIFIC NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 202. ASIA-PACIFIC NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTING RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 203. ASIA-PACIFIC NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE TYPE, 2018-2032 (USD MILLION)
TABLE 204. ASIA-PACIFIC NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED ISOTOPES, 2018-2032 (USD MILLION)
TABLE 205. ASIA-PACIFIC NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED ISOTOPES, 2018-2032 (USD MILLION)
TABLE 206. ASIA-PACIFIC NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 207. ASIA-PACIFIC NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 208. ASIA-PACIFIC NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 209. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 210. ASEAN NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. ASEAN NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 212. ASEAN NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 213. ASEAN NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 214. ASEAN NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 215. ASEAN NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 216. ASEAN NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTING RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 217. ASEAN NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE TYPE, 2018-2032 (USD MILLION)
TABLE 218. ASEAN NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED ISOTOPES, 2018-2032 (USD MILLION)
TABLE 219. ASEAN NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED ISOTOPES, 2018-2032 (USD MILLION)
TABLE 220. ASEAN NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 221. ASEAN NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 222. ASEAN NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 223. GCC NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 224. GCC NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 225. GCC NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 226. GCC NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 227. GCC NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 228. GCC NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 229. GCC NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTING RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 230. GCC NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE TYPE, 2018-2032 (USD MILLION)
TABLE 231. GCC NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED ISOTOPES, 2018-2032 (USD MILLION)
TABLE 232. GCC NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED ISOTOPES, 2018-2032 (USD MILLION)
TABLE 233. GCC NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 234. GCC NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 235. GCC NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTING RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE TYPE, 2018-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED ISOTOPES, 2018-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED ISOTOPES, 2018-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 249. BRICS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 250. BRICS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 251. BRICS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 252. BRICS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 253. BRICS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 254. BRICS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 255. BRICS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTING RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 256. BRICS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE TYPE, 2018-2032 (USD MILLION)
TABLE 257. BRICS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED ISOTOPES, 2018-2032 (USD MILLION)
TABLE 258. BRICS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED ISOTOPES, 2018-2032 (USD MILLION)
TABLE 259. BRICS NUCLEAR MEDICINE & RADIOPHARMACEUTICA

Companies Mentioned

The key companies profiled in this Nuclear Medicine & Radiopharmaceuticals market report include:
  • Advanced Accelerator Applications S.A.
  • AstraZeneca PLC
  • Bayer AG
  • Bracco Imaging S.p.A.
  • Bristol-Myers Squibb Company
  • BWX Technologies, Inc.
  • Cardinal Health, Inc.
  • Clarity Pharmaceuticals Ltd.
  • Curium Pharma
  • Eckert & Ziegler SE
  • Eli Lilly and Company
  • GE HealthCare Technologies Inc.
  • Ion Beam Applications S.A.
  • ITM Isotope Technologies Munich SE
  • Jubilant Pharmova Limited
  • Lantheus Holdings, Inc.
  • NorthStar Medical Radioisotopes, LLC
  • Novartis AG
  • Siemens Healthineers AG
  • Telix Pharmaceuticals Limited

Table Information

Report AttributeDetails
No. of Pages194
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 10.07 Billion
Forecasted Market Value ( USD ) by 2032 $ 15.12 Billion
Compound Annual Growth Rate6.8%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Radiopharmaceuticals in Nuclear Medicine Market - Global Forecast 2026-2032 - Product Image

Radiopharmaceuticals in Nuclear Medicine Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Nuclear Radiopharmaceutical Market - Global Forecast 2026-2032 - Product Image

Nuclear Radiopharmaceutical Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Nuclear Medicine Market Report and Forecast 2025-2034 - Product Image

Nuclear Medicine Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Radiopharmaceuticals Market Growth Analysis Report - Market Size, Share, Forecast Trends and Outlook (2025-2034) - Product Image

Radiopharmaceuticals Market Growth Analysis Report - Market Size, Share, Forecast Trends and Outlook (2025-2034)

  • Report
  • 400 Pages
  • Global
From
Radiopharmaceutical Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application - Product Image

Radiopharmaceutical Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application

  • Report
  • 84 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.